Evolution and Adaptation to Caregiver of a Socio-geriatric Evaluation
NCT ID: NCT05062590
Last Updated: 2024-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
260 participants
INTERVENTIONAL
2022-04-04
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
First Level Socio-geriatric Evaluation: ESOGER Databank
NCT04393649
E-health and People Living With Major Neurocognitive Disorder - CARE© and ESOGER© Applications
NCT05571553
Social Deprivation Assessment in Older Adults
NCT04105036
Intervention to Improve Shared Decision Making Among Seniors With Dementia, Their Caregivers and Healthcare Providers
NCT02956694
Intervention to Collect and Utilize Sexual Orientation and Gender Identity (SOGI) Information in Hospice
NCT05877391
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group Intervention
Experimental: Group 1 The intervention group will take the ESOGER questionnaire at month 0 and month 3 ( beginning and end) and receive recommendations following their needs.
Recommendations
Ressources recommendations and interventions curated to the needs of the EP such as refering them to a social activity for socially isolated EP
Group control
The participants will only take the ESOGER questionnaire at month 0 and month 3 without recommendations
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Recommendations
Ressources recommendations and interventions curated to the needs of the EP such as refering them to a social activity for socially isolated EP
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Living at home on the territory CIUSSS-Centre-Sud de l'île-de-Montréal (CCSMTL) of Jeanne-Mance
* Brief Geriatric Assessment (BGA) score of 1/14 or more defining a severly to milidly frail health.
Exclusion Criteria
* Participate at another clinical trial, to avoid interferences
* Not understand written or spoken French or English, questionnaires are only available in French and English.
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Olivier Beauchet
MD, PhD, Senior researcher, Director of laboratory
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CRIUGM
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Kévin Galéry
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-616
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.